Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Talevich

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Pigment Cell & Melanoma Research|August 30, 2018
The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanomaJoshua D Webster, Trang H Pham, Xiumin Wu, et al.
JAMA Neurology|September 13, 2021
Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal FluidWei Gu, Andreas M Rauschecker, Elaine Hsu, et al.
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Nature Communications|February 25, 2018
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricleBenjamin Goode, Gourish Mondal, Michael Hyun, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Pigment Cell & Melanoma Research|August 30, 2018
The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanomaJoshua D Webster, Trang H Pham, Xiumin Wu, et al.
JAMA Neurology|September 13, 2021
Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal FluidWei Gu, Andreas M Rauschecker, Elaine Hsu, et al.
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Nature Communications|February 25, 2018
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricleBenjamin Goode, Gourish Mondal, Michael Hyun, et al.
Pageof 3